주식회사 시선테라퓨틱스

{
  "address": "대전광역시 유성구",
  "ceo_name": "박희경",
  "certificate": [
    {
      "cert_number": "20190300769",
      "changes": "",
      "disclosure_date": "2019-08-22",
      "first_cert_date": "2019-08-22",
      "no": "1",
      "type": "벤처투자유형",
      "valid_period": "2019-08-22 ~ 2021-08-21"
    },
    {
      "cert_number": "20210826010021",
      "changes": "",
      "disclosure_date": "2021-08-26",
      "first_cert_date": "2019-08-22",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2021-08-22 ~ 2024-08-21"
    },
    {
      "cert_number": "20240827010009",
      "changes": "대표자, 소재지",
      "disclosure_date": "2024-08-27",
      "first_cert_date": "2019-08-22",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2024-08-22 ~ 2027-08-21"
    }
  ],
  "company_name": "주식회사 시선테라퓨틱스",
  "corp_no": "160111-*******",
  "financials": {
    "2022": {
      "capital_stock": 295361000,
      "cost_of_sales": 0,
      "current_assets": 930073000,
      "current_liabilities": 1145938000,
      "gross_profit": 0,
      "net_income": -1047035000,
      "net_income_bs": -1047035000,
      "non_current_assets": 1074032000,
      "non_current_liabilities": 671150000,
      "non_operating_expenses": 41050000,
      "non_operating_income": 663482000,
      "operating_profit": -1669467000,
      "revenue": 0,
      "sga_expenses": 1669467000,
      "total_assets": 2004105000,
      "total_equity": 187017000,
      "total_liabilities": 1817088000
    },
    "2023": {
      "capital_stock": 298257000,
      "cost_of_sales": 0,
      "current_assets": 475783000,
      "current_liabilities": 1203216000,
      "gross_profit": 0,
      "net_income": -727960000,
      "net_income_bs": -727960000,
      "non_current_assets": 1128168000,
      "non_current_liabilities": 260068000,
      "non_operating_expenses": 54507000,
      "non_operating_income": 484920000,
      "operating_profit": -1158373000,
      "revenue": 0,
      "sga_expenses": 1158373000,
      "total_assets": 1603951000,
      "total_equity": 140667000,
      "total_liabilities": 1463284000
    },
    "2024": {
      "capital_stock": 306947000,
      "cost_of_sales": 0,
      "current_assets": 123696000,
      "current_liabilities": 525917000,
      "gross_profit": 0,
      "net_income": -933327000,
      "net_income_bs": -933327000,
      "non_current_assets": 759864000,
      "non_current_liabilities": 44929000,
      "non_operating_expenses": 19035000,
      "non_operating_income": 8897000,
      "operating_profit": -923189000,
      "revenue": 0,
      "sga_expenses": 923189000,
      "total_assets": 883560000,
      "total_equity": 312714000,
      "total_liabilities": 570846000
    }
  },
  "industry": "의학 및 약학 연구개발업",
  "investment": [
    {
      "amount": "2,640,000,000",
      "changes": "2,640,000,000",
      "date": "2021-06-30"
    },
    {
      "amount": "2,640,944,200",
      "changes": "2,640,944,200",
      "date": "2021-06-30"
    },
    {
      "amount": "700,620,000",
      "changes": "700,620,000",
      "date": "2019-07-25"
    }
  ],
  "main_products": "의약품",
  "phone": "042-721-****",
  "years": [
    2024,
    2023,
    2022
  ]
}